RXDX.OQ

Chart for RXDX.OQ

About

Prometheus RxDx Corp., a wholly owned subsidiary of Prometheus Laboratories Inc., is engaged in the development and commercialization of pharmaceutical and diagnostic products that enable physicians to provide individualized patient care. It focuses on the detection, diagnosis and treatment of disorders within the fields of... (more)
No analyst recommendations are available for RXDX.OQ.

Overall

No Ratios Available.

Financials

  RXDX.OQ Industry Sector
P/E (TTM): -- 32.65 33.52
EPS (TTM): -- -- --
ROI: -- 18.10 17.33
ROE: -- 18.80 18.19
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks